Wells Fargo Maintains Equal-Weight on Bristol-Myers Squibb, Raises Price Target to $55

Benzinga · 1d ago
Wells Fargo analyst Mohit Bansal maintains Bristol-Myers Squibb (NYSE:BMY) with a Equal-Weight and raises the price target from $53 to $55.